Copay Fairness for Veterans Act of 2026
SB 4217, the Copay Fairness for Veterans Act of 2026, would prohibit the Department of Veterans Affairs from charging copayments for a broad set of preventive health services and related medicines. The bill amends multiple provisions of title 38 of the U.S. Code to extend copay relief across VA hospital care, nursing home care, walk-in care, and care for survivors and dependents. It also expands the statutory definition of preventive health services to include immunizations, evidence-based preventive items and services, screenings, counseling, breastfeeding support, contraception and related services, obesity prevention in midlife women, and well-woman preventive visits.
The bill further clarifies that preventive services may be identified through USPSTF recommendations, CDC immunization guidance, and recommendations from major professional organizations. It includes a rule of construction stating that the amendments should not be read to reduce existing preventive-service coverage and should not limit coverage of preventive health services, screenings, or contraceptive services when provided according to evidence-based standards of care. The bill would take effect 180 days after enactment.
If enacted, the bill would amend title 38 of the United States Code and directly change VA billing rules by eliminating copayments for specified preventive services and preventive medications. It would affect veterans receiving VA care, as well as certain survivors and dependents covered under VA programs, by removing out-of-pocket charges for preventive care delivered through hospital, nursing home, walk-in, and related VA services. The measure would also broaden the statutory definition of preventive health services, which could influence how the VA administers and interprets covered preventive care going forward.
The available context suggests generally favorable treatment of the bill, with no recorded votes or committee objections in the materials provided. The bill was introduced by Senators Duckworth and Collins, indicating bipartisan sponsorship, and its title and structure frame it as a fairness and access measure for veterans. Because there are no committee transcripts or vote tallies, there is no documented opposition in the provided record, but the bill’s expansion of preventive and contraceptive coverage suggests it could draw policy interest from stakeholders focused on VA benefits and reproductive health.
The main potential points of contention are the breadth of the preventive-services definition and the inclusion of contraception, screenings, and related services within the copay exemption. Some stakeholders may question whether the bill should rely on USPSTF, CDC, and professional-organization recommendations to define covered services, or whether that approach gives too much discretion to evolving medical standards. Another possible area of debate is the fiscal impact on the VA from eliminating copay revenue, though no specific opposition or cost concerns appear in the provided record.